Previous studies have documented that PAK1 is amplified in BRAF wild type tumors [46] and identified PAK inhibitors as agents that can slow the growth of melanoma xenografts [47] and synergize with BRAF inhibitors to kill melanoma cells [48]. The gene discussed is PAK1; the disease is melanoma.